Drug Type Small molecule drug |
Synonyms (-)-Gusperimus, 15-Deoxyspergualin, 15-Desoxyspergualin + [19] |
Target |
Action inhibitors |
Mechanism Cytokines inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (19 Jan 1994), |
RegulationOrphan Drug (United States) |
Molecular FormulaC17H40Cl3N7O3 |
InChIKeyAXSPHUWXYSZPBG-UHFFFAOYSA-N |
CAS Registry85468-01-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Deoxyspergualin hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Renal transplant rejection | Japan | 19 Jan 1994 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | NDA/BLA | France | - | |
Multiple Sclerosis | NDA/BLA | Germany | - | |
Granulomatosis With Polyangiitis | Phase 3 | Germany | - | |
Granulomatosis With Polyangiitis | Phase 3 | Spain | - | |
Granulomatosis With Polyangiitis | Phase 3 | Sweden | - | |
Granulomatosis With Polyangiitis | Phase 3 | United Kingdom | - | |
wegener's granuloma | Phase 2 | Czechia | 01 Dec 2003 | |
wegener's granuloma | Phase 2 | Denmark | 01 Dec 2003 | |
wegener's granuloma | Phase 2 | Germany | 01 Dec 2003 | |
wegener's granuloma | Phase 2 | Netherlands | 01 Dec 2003 |
Phase 1/2 | 21 | txkoiyytzd(totmfozrec) = Five patients dropped out due to adverse events or serious adverse events including fever, leukopenia, oral candidiasis, herpes zoster or pneumonia ripqotbttd (pktzeypvby ) View more | - | 01 Apr 2011 | |||
Phase 1/2 | 3 | 15-Deoxyspergualin (15-DSG) | huoaboyjzr(vjqbdslblt) = No SAE were observed pslunxvfdz (zngcqndfbk ) | Positive | 09 Jun 2004 |